PL EN
RESEARCH PAPER
Eyelid Skin Disorders and Their Impact on the Ocular Surface
 
 
More details
Hide details
1
Department of Ophthalmology, Faculty of Medical Sciences in Katowice, Medical University of Silesia in Katowice, Poland
Head: Prof. Dorota Wyględowska-Promieńska, PhD, MD
 
2
Kornel Gibiński University Clinical Center, Medical University of Silesia in Katowice, Poland
Head: Prof. Dorota Wyględowska-Promieńska, PhD, MD
 
 
Submission date: 2024-11-15
 
 
Acceptance date: 2024-12-02
 
 
Publication date: 2025-03-29
 
 
Ophthalmology 2024;27(4):24-31
 
KEYWORDS
ABSTRACT
The skin is a barrier between the body and the external environment, it is the largest human organ. Healthy skin microbiota is harmless and beneficial to the skin. As a microbiological barrier, it protects against harmful microorganisms. In turn, the eyelids protect the surface of the eyeball from the adverse effects of external factors. The skin of the eyelids is the thinnest skin in the human body, it is extremely delicate, and does not have subcutaneous fat. The paper discusses eyelid disorders, symptoms accompanying eyelid disorders, including: dry and rough eyelid skin, redness of the eye, a burning/stinging sensation, irritation with a feeling of a foreign body, and others. The author draws attention to the fact that problems with the skin of the eyelids begin when the protective barrier of the skin is breached, which causes an imbalance in the skin microbiota, and the processes that occur then may contribute to the development of skin diseases. The paper discusses the influence of cosmetics on the condition of the eyelid skin, and thus the eye surface, and the importance of trehalose 3%, hyaluronic acid 0.15% and Ophiopogon japonicus 0.3% as ingredients of a cream for the treatment of eyelid skin disorders. The paper discusses the case of a 78-year-old patient treated for many years for glaucoma, with chronic eye surface disorders of a toxic-allergic etiology to the drug reaction, which was treated with the use of the newest three-component cream.
REFERENCES (25)
1.
Carvalho MJ, Oliveira AS, Santos Pedrosa S, et al.: Skin Microbiota and the Cosmetic Industry. Microb Ecol. 2022 Jul, Forthcoming.
 
2.
Lopez-Ojeda W, Pandey A, Alhajj M, et al.: In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan. 2022 Oct 17., et al.: Anatomy, Skin (Integument) - StatPearls - NCBI Bookshelf (nih.gov). Last Update October 17th 2022.
 
3.
Arda O, Göksügür N, Tüzün Y: Basic histological structure and functions of facial skin. Clinics in Dermatology. 2014; 32: 3–13. DOI: 10.1016/j.clindermatol.2013.05.021.
 
4.
Byrd AL, Belkaid Y, Segre JA: The Human skin microbiome. Nature Reviews Microbiology. 2018; 16: 143–155.
 
5.
Harris-Tyrin TA, Grice EA: Microbiota and maintenance of skin barrier function. Science. 2022; 376: 940–945.
 
6.
Baldwin HE, Bhatia ND, Friedman A, et al.: The Role of Cutaneous Micro­biota Harmony in Maintaining a Functional Skin Barrier. Journal of Drugs in Dermatology. 2017 Jan 1; 16(1): 12–18.
 
7.
Wallen-Russell C, Wallen-Russell S: Meta analysis of skin microbiome: new link between skin microbiota diversity and skin health with proposal to use this as a future mechanism to determine whether cosmetic products damage the skin. Cosmetics. 2017; 4: 1–19.
 
8.
Cochran ML, Lopez MJ, Czyz CN: Anatomy, Head and Neck: Eyelid. StatPearls Publishing. 2023. PMID: 29493929 Bookshelf ID: NBK482304.
 
9.
Hwang K, Kim DJ, Se Ho Hwang SH: Thickness of Korean Upper Eyelid Skin at Different levels. Journal of Carniofacila Surgery. 2006 January 17; 1: 54–56.
 
10.
Pratchyapruit W, Kikuchi K, Gritiyarangasan P, et al.: Functional analyses of the eyelid skin constituting the most soft and smooth area on the face: contribution of its remarkably large superficial corneocytes to effective water-holding capacity of the stratum corneum. Skin Res Technol. 2007 May 13; 2: 169–175.
 
11.
Doan S, Zagórski Z, Palmares J, et al.: Eyelid Disorders in Ophthalmology Practice: Results from a Large International Epidemiological Study in Eleven Countries. Ophthalmology and Therapy. 2020; 9(3): 597–608. doi: 10.1007/s40123-020-00268-4.
 
12.
Németh D, Temesvári E, Holló P, et al.: Preservative Contact Hypersensitivity among Adult Atopic Dermatitis Patients. Life. 2022; 12(5): 715.
 
13.
Wolf R, Orion E, Tüzün Y: Periorbital (eyelid) dermatides. Clinics in Dermatology. 2014; 32: 131–140.
 
14.
Tavassoli S, Wong N, Chanet E: Ocular manifestations of rosacea: A clinical review. Clin Exp Ophthalmol. 2021 Mar; 49(2): 104–117.
 
15.
Laihia J, Kaarniranta K: Trehalose for Ocular Surface Health. Biomolecules. 2020 May 25; 10(5), 809: 3–15.
 
16.
Ohtake S, Wang YJ: Trehalose: Current Use and Future Applications. J Pharm Sci. 100: 2020–2053, 2011: 4–16.
 
17.
Li L, Chen H, Chen X, Chen S, et al.: Trehalose Protects Keratinocytes against Ultraviolet B Radiation by Activating Autophagy via Regulating TIMP3 and ATG9. AOxid Med Cell Longev. 2022; 9366494, 6–17.
 
18.
Messaraa C, Drevet J, Jameson D, et al.: Can Performance and Gentleness Be Reconciled? A Skin Care Approach for Sensitive Skin. Cosmetics. 2022; 9: 34. https://doi.org/10.3390/cosmet....
 
19.
Chen M-H, Chen X-J, Wang M, et al.: Ophiopogon Japonicus ---A phytochemical, ethnomedicinal and pharmacological review. J Ethnopharmacol. 2016; 181: 193–213.
 
20.
Valeille A, Ouilhon C, Hacard F, et al.: Evaluation ophtalmologique complète dans la DA: identification des critères d’orientation en ophtalmologie. Revue Française d’Allergologie. 2021; 61, 4: 259.
 
21.
Kliniczna ocena tolerancji i skuteczności BLEPHADERM® w pielęgnacji skóry atopowej przez skórę i oczy. Badanie 22E-1350.
 
22.
Ocena efektu przeznaskórkowej utraty wody i długotrwałego działania nawilżającego BLEPHADERM®. Studium 22 E-1351.
 
23.
Kliniczna ocena tolerancji i skuteczności BLEPHADERM® przez skórę i oczy. Badanie 18E-2458.
 
24.
Kliniczna ocena natychmiastowego łagodzącego działania produktu kosmetycznego BLEPHADERM® metodą testu pieczenia. Badanie 22E-1374.
 
25.
Ocena potencjału uczulającego produktu kosmetycznego: końcowy test bezpieczeństwa klinicznego pod kontrolą dermatologiczną. Badanie 18E-3120.
 
eISSN:1689-362X
ISSN:1505-2753
Journals System - logo
Scroll to top